Castle Biosciences (CSTL) Q4 2023 Earnings

28FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.1
-0.77
-0.43
-0.1

Details

Expected EPS
-0.562372
Actual EPS
-0.1
Surprise EPS
0.46
Surprise Percent
+82.22%

Description

Castle Biosciences (CSTL) has reported earnings of -0.1 per share for Q4 2023.

0 Comments

Share your thoughts